NCT03811847

Study ID(s) and Acronym(s)
NCT03811847
Current Status of Trial
Ongoing
Study Aim
Treatment Dementia
Study Design
RCT
Blinding
Double-blind
Intervention type
Pharmacological
Intervention
Methylphenidate // Placebo
Dosage and Duration
A crossover study. During this study participants will get both the study drug Methylphenidate Extended Release Capsule and the placebo in random order
Absolute Number of Participants
8
Health Status/Diagnosis
Alzheimer Disease (AD)
Study completion date
Estimated primary completion date: January 30, 2021
Primary outcomes
Cognition